Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$31.15 - $33.39 $71,645 - $76,797
-2,300 Reduced 8.65%
24,300 $807,000
Q3 2022

Oct 27, 2022

BUY
$30.9 - $33.55 $312,090 - $338,855
10,100 Added 61.21%
26,600 $838,000
Q2 2022

Jul 25, 2022

BUY
$23.75 - $31.69 $23,750 - $31,690
1,000 Added 6.45%
16,500 $501,000
Q1 2022

Apr 21, 2022

BUY
$19.97 - $26.94 $309,535 - $417,570
15,500 New
15,500 $402,000
Q2 2021

Jul 26, 2021

SELL
$18.01 - $28.32 $271,951 - $427,632
-15,100 Closed
0 $0
Q1 2021

Apr 23, 2021

SELL
$19.76 - $29.89 $446,576 - $675,514
-22,600 Reduced 59.95%
15,100 $396,000
Q3 2020

Dec 14, 2020

BUY
$13.54 - $26.41 $39,266 - $76,589
2,900 Added 8.33%
37,700 $640,000
Q2 2020

Jul 23, 2020

BUY
$7.84 - $23.29 $272,832 - $810,492
34,800 New
34,800 $810,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.